Patents by Inventor Firdausi Qadri

Firdausi Qadri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10288610
    Abstract: Provided are assays, kits and compositions for testing subjects, particularly asymptomatic subjects, to ascertain whether or not they are carriers of Salmonella enterica serotype Typhi. Methods for detecting the presence of Salmonella enterica serotype Typhi indicating molecules by a variety of methods such as immunoassays and mass spectrometry also are provided.
    Type: Grant
    Filed: November 12, 2013
    Date of Patent: May 14, 2019
    Assignees: THE GENERAL HOSPITAL CORPORATION, INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH, BANGLADESH (ICDDR,B), THE CHANGELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
    Inventors: Richelle Charles, Edward T. Ryan, Firdausi Qadri, Stephen Baker
  • Publication number: 20170160275
    Abstract: The blood-based lateral-flow dipstick assay for detection of enteric fever is an immunochromatographic dipstick assay based on detection of Salmonella enterica serovar Typhi (S. Typhi) LPS-specific IgG in lymphocyte culture secretion. The dipstick has a test line of an S. Typhi strain antigen extending across a chromatographic stationary phase disposed on a backing, A conjugate pad of glass fibers is attached to the backing so that it overlaps the stationary phase. The conjugate pad is soaked in a first mammal's anti-human antibody (e.g., goat anti-human IgG) conjugated with a color indicator (e.g., colloidal gold nanoparticles exhibiting a wine red color). When dipped in a lymphocyte culture of a human enteric fever victim, the test line turns to the color of the color indicator. A control line of anti-first mammal antibody across the stationary phase changes to the color of the indicator so long as the conjugated anti-human antibody remains viable.
    Type: Application
    Filed: December 2, 2016
    Publication date: June 8, 2017
    Inventors: FIRDAUSI QADRI, JAKIA AMIN
  • Patent number: 9616139
    Abstract: The disclosure provides directly conjugated polysaccharide vaccine molecules and methods related thereto.
    Type: Grant
    Filed: July 11, 2012
    Date of Patent: April 11, 2017
    Assignees: The General Hospital Corporation, The United States, as represented by the secretary, Department of Health and Human Services, International Centre for Diarrhoeal Disease Research, Bangladesh
    Inventors: Edward T. Ryan, Pavol Kovac, Firdausi Qadri, Peng Xu, Stephen B. Calderwood, Willie Frank Vann, Dwight Christopher Peterson
  • Publication number: 20150293093
    Abstract: Provided are assays, kits and compositions for testing subjects, particularly asymptomatic subjects, to ascertain whether or not they are carriers of Salmonella enterica serotype Typhi. Methods for detecting the presence of Salmonella enterica serotype Typhi indicating molecules by a variety of methods such as immunoassays and mass spectrometry also are provided.
    Type: Application
    Filed: November 12, 2013
    Publication date: October 15, 2015
    Inventors: Richelle Charles, Edward T. Ryan, Firdausi Qadri, Stephen Baker
  • Publication number: 20150031863
    Abstract: The disclosure provides directly conjugated polysaccharide vaccine molecules and methods related thereto.
    Type: Application
    Filed: July 11, 2012
    Publication date: January 29, 2015
    Applicant: The General Hospital Corporation
    Inventors: Edward T. Ryan, Pavol Kovac, Firdausi Qadri, Peng Xu, Stephen B. Calderwood, Willie Frank Vann, Dwight Christopher Peterson